The Food and Drug Administration issued a warning in June 2011 that diabetic patients who have taken Actos and other pioglitazone-containing medicines are at a higher risk of developing bladder cancer. The warning notes that the risk is higher in patients who have taken higher dosages of Actos for more than 12 months.
France has stopped the release of these drugs. The FDA noted that it was aware of France’s decision. However, the FDA has not banned these medicines from being issued in the United States.
Gersowitz Libo & Korek, P.C. has been researching patients who have developed bladder cancer as a result of taking Actos and is now accepting new clients. If you or a loved one has fallen victim to the drug Actos, contact Gersowitz Libo & Korek, P.C. at (800) 529-9997 to learn your legal rights.
Two People Died After 72 People Infected From Legionnaires’ Disease Outbreak Linked to the Upper…
Cyclosporiasis Outbreak in Suffolk County May Be Linked to Contaminated Produce SUFFOLK COUNTY, CALIFORNIA (July…
Van Was Traveling Westbound on Spiegelhagen Street Before Hitting Two Pedestrians While Turning LINDENHURST, NEW…
Schools, Nursing Homes, and Met Museum Among Buildings Ordered to Clean Cooling Towers After Another…
Elderly Man Seriously Injured in Smithtown House Fire Along 115A Oakside Drive SMITHTOWN, NEW YORK…
Investigation Underway After Man Killed in East New York, Brooklyn Pedestrian Accident With Garbage Truck…